What are - this understanding of receptor-ligand interactions has been really the biological basis of much of the pharmaceutical industry.

受体-配体相互作用理论,现在已经成为很多,制药工业的生物学基础

耶鲁公开课 - 生物医学工程探索课程节选

Western countries, and especially the United States say, "We have a big pharmaceutical industry that develops new drugs.

西方国家，尤其是美国宣称，我们拥有研发新药品的大制药业。

耶鲁公开课 - 公正课程节选

So, this is, in fact, what's used to make novacaine in industry.

因此，这实际上是，在制药业中用来制造奴佛卡因的。

麻省理工公开课 - 化学原理课程节选

Much of the work that pharmaceutical companies do in terms of searching for drugs is searching for new ligands that activate receptors and create biological responses inside cells.

很多制药公司新药筛选工作的主要内容,就是寻找能够激活受体的,新型配体,并在细胞内部产生某种生物学效应

耶鲁公开课 - 生物医学工程探索课程节选

This is what's used in industry to actually make novacaine.

这就是在制药业中真正用来制造奴佛卡因的流程。

麻省理工公开课 - 化学原理课程节选

And the reason I was able to do that and keep with what my original intentions were was to have a career that was the fulfilling, in terms of helping people and being engaged in science, is all of a sudden I realized, as chemists, we can think about better ways to build molecules that are important for making medications.

我能够这么做,并且能不和我原来的打算冲突,是因为我的职业很有意义，能帮助他人，又和科学相关,于是突然我意思到，作为一个化学家,我们可以思考出更好的办法,制造出在制药方面十分有用的分子。

麻省理工公开课 - 化学原理课程节选